(Q44590797)

4 December 2017

Genetic evidence for involvement of classical complement pathway in induction of experimental autoimmune myasthenia gravis (English)

1 reference

4 December 2017

Genetic Evidence for Involvement of Classical Complement Pathway in Induction of Experimental Autoimmune Myasthenia Gravis (English)

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3847

12 March 2024

0 references

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3847

12 March 2024

4

Stephen Higgs

1 reference

4 December 2017

Erdem Tüzün

1

1 reference

4 December 2017

Elzbieta Goluszko

3

1 reference

4 December 2017

Premkumar Christadoss

5

1 reference

4 December 2017

Benjamin G. Scott

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14500686

12 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

full work available at URL

4 December 2017

published in

Journal of Immunology

1 reference

4 December 2017

171

1 reference

4 December 2017

7

1 reference

4 December 2017

3847-3854

1 reference

In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class II genes

4 December 2017

1

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3847

Diagnostic significance of IgG, C3, and C9 at the limb muscle motor end-plate in minimal myasthenia gravis

12 March 2024

5

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3847

Absence of IFN-gamma or IL-12 has different effects on experimental myasthenia gravis in C57BL/6 mice

12 March 2024

6

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3847

Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis

12 March 2024

8

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3847

Markedly enhanced susceptibility to experimental autoimmune myasthenia gravis in the absence of decay-accelerating factor protection

12 March 2024

9

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3847

29 Production and assay of antibodies to acetylcholine receptors

12 March 2024

10

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3847

Phylogenetic Analysis of the Homologous Proteins of the Terminal Complement Complex Supports the Emergence of C6 and C7 Followed by C8 and C9

12 March 2024

12

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3847

Polymorphic markers in MHC class II/III region: a study on Italian patients with myasthenia gravis

12 March 2024

13

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3847

HLA, anti-DNA, and complement in myasthenia gravis

12 March 2024

14

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3847

Immune complexes in myasthenia gravis

12 March 2024

15

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3847

Letter: Immune complexes in myasthenia gravis

12 March 2024

16

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3847

Soluble complement receptor 1 (sCR1) protects against experimental autoimmune myasthenia gravis

12 March 2024

17

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3847

Monoclonal autoantibodies to acetylcholine receptors: evidence for a dominant idiotype and requirement of complement for pathogenicity

12 March 2024

18

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3847

Mannose-binding lectin (MBL) in health and disease

12 March 2024

19

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3847

Anti-DNA autoreactivity in C4-deficient mice

12 March 2024

21

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3847

Use of Torpedo-mouse hybrid acetylcholine receptors reveals immunodominance of the alpha subunit in myasthenia gravis antisera

12 March 2024

23

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3847

Ultrastructural Localization of Immune Complexes (IGG and C3) at the End-Plate in Experimental Autoimmune Myasthenia Gravis

12 March 2024

26

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3847

Resistance to experimental autoimmune myasthenia gravis in IL-6-deficient mice is associated with reduced germinal center formation and C3 production.

12 March 2024

28

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3847

HLA-DQ6 transgenic mice resistance to experimental autoimmune myasthenia gravis is linked to reduced acetylcholine receptor-specific IFN-gamma, IL-2 and IL-10 production

12 March 2024

29

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3847

Role of complement receptors CD21/CD35 in B lymphocyte activation and survival

12 March 2024

30

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3847

Mutation at I-A beta chain prevents experimental autoimmune myasthenia gravis.

12 March 2024

32

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3847

Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity

12 March 2024

35

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3847

12 March 2024

Identifiers

1 reference

4 December 2017

1 reference